News
D-Wave Quantum’s QBTS standout growth catalyst this quarter is the successful launch and commercial deployment of its next-generation Advantage2 quantum annealer. In the last-reported quarter, the ...
A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback